Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.44M Buy
101,513
+1,530
+2% +$40K 0.03% 314
2026
Q1
$2.81M Sell
99,983
-4,730
-5% -$126K 0.03% 302
2025
Q4
$2.61M Buy
104,713
+23,242
+29% +$586K 0.03% 304
2025
Q3
$2.08M Buy
81,471
+15,567
+24% +$384K 0.03% 302
2025
Q2
$1.6M Buy
65,904
+18,652
+39% +$435K 0.02% 304
2025
Q1
$1.2M Buy
47,252
+20,018
+74% +$524K 0.02% 303
2024
Q4
$723K Buy
27,234
+3,573
+15% +$96.9K 0.01% 248
2024
Q3
$685K Buy
23,661
+15,781
+200% +$460K 0.01% 240
2024
Q2
$220K Sell
7,880
-246
-3% -$6.77K 0.01% 252
2024
Q1
$225K Sell
8,126
-459,851
-98% -$12.8M 0.01% 257
2023
Q4
$13.5M Buy
467,977
+197,317
+73% +$5.96M 0.5% 76
2023
Q3
$8.98M Buy
270,660
+140,281
+108% +$4.96M 0.49% 85
2023
Q2
$4.79M Buy
130,379
+96,726
+287% +$3.76M 0.45% 110
2023
Q1
$1.37M Buy
33,653
+26,272
+356% +$1.13M 0.19% 104
2022
Q4
$378K Buy
+7,381
New +$354K 0.06% 93

Other funds holding PFE

Vest Financial's PFE Position: Q2 2026 in Review

Vest Financial increased its Pfizer (PFE) stake by 1.5% in Q2 2026, buying an estimated $40K and bringing the position to 101,513 shares worth $2.44M. The position accounts for 0.03% of the portfolio, ranked #314.

Vest Financial first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $13.5M in Q4 2023. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vest Financial held 101,513 shares of Pfizer worth $2.44M as of Q2 2026.
  • Vest Financial bought 1,530 Pfizer shares in Q2 2026, an estimated $40K.
  • Pfizer made up 0.03% of Vest Financial's portfolio in Q2 2026, its #314 holding.
  • Vest Financial first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Vest Financial's Pfizer position peaked at $13.5M in Q4 2023.
  • 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vest Financial's 13F filing for Q2 2026, filed 24 Jul 2026.